French pharmaceutical company Sanofi and Google today announced its plan to establish a new virtual Innovation Lab that will leverage emerging data technologies to spur the transformation of healthcare delivery. The partnership will change how Sanofi develops new treatments and will focus on three key objectives
1. Better understand patients and diseases,
2. Incease Sanofi’s operational efficiency
3. Improve the experience of Sanofi’s patients and customers
Want to publish your own articles on DistilINFO Publications?
Send us an email, we will get in touch with you.
Virtual Innovation Lab Details
Together, the virtual Innovation Lab will leverage deep analytics across data sets to better understand key diseases and extract related patient insights. This will enable Sanofi to research and develop more personalized approaches to treatment and identify accompanying technologies to improve health outcomes. The companies will apply technology and analytics on Sanofi’s real-world evidence (RWE) database to better understand what treatments work for patients. This aims to result in an improved ability to offer personalized treatment advice, thus optimizing patient care and reducing healthcare costs.
Applying AI Across Datasets
Sanofi and Google also plan to apply artificial intelligence (AI) across diverse datasets to better forecast sales and inform marketing and supply chain efforts. Using AI will take into account real-time information as well as geographic, logistics and manufacturing constraints to help the accuracy of these complex activities.
Sanofi IT Migration to Google Cloud Platform
Additionally, Sanofi IT will be modernizing its infrastructure by migrating some existing business apps to Google Cloud Platform (GCP). By leveraging automation, scalability, and agility—along with increases in data and analytic capabilities—Sanofi will accelerate and simplify legacy management, provide easy access to recent technologies and its integration into business plans. The transition to GCP will maximize operational cost efficiency and support business objectives, including the Innovation Lab.
Impact of Innovation Lab
“We stand on the forefront of a new age for biology and human health, with the opportunity to transform healthcare through partnerships with pioneering technology and analytics companies,” says Ameet Nathwani, M.D., Chief Digital Officer, Chief Medical Officer & Executive Vice President, Medical at Sanofi. “Combining Sanofi’s biologic innovations and scientific data with Google’s industry-leading capabilities, from cloud computing to state-of-the-art artificial intelligence, we aspire to give people more control over their health and accelerate the discovery of new therapies.”
Date: June 26, 2019
Source: HIT Consultant
